The who, where, and when of IgE in allergic airway disease

    loading  Checking for direct PDF access through Ovid

Abstract

Allergic asthma and allergic rhinitis/conjunctivitis are characterized by a TH2-dominated immune response associated with increased serum IgE levels in response to inhaled allergens. Because IgE is a key player in the induction and maintenance of allergic inflammation, it represents a prime target for therapeutic intervention. However, our understanding of IgE biology remains fragmentary. This article puts together our current knowledge on IgE in allergic airway diseases with a special focus on the identity of IgE-secreting cells (“who”), their location (“where”), and the circumstances in which they are induced (“when”). We further consider the therapeutic implications of the insights gained.

Related Topics

    loading  Loading Related Articles